Stock Updates

How has Bristol-Myers Squibb Company:(NYSE:BMY) performed recently?

Bristol-Myers Squibb Company (NYSE: BMY) is a large market cap stock with a market cap of 123138.82. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 78.82, a forward P/E of 22.93 and EPS of 0.94. At a stock price of 73.78 (0.00%) it has a dividend yield of 2.06%.

EPS growth for the last five years have been -12.20%, more recently this last year it has grown by -22.30%. The next year growth is going to be about 25.80% and more long-term 22.85% after five years. EPS growth quarter over quarter is 0.50%. Sales growth for the past five years have been -3.20% and sales growth quarter over quarter is 8.70%.

For performance, Bristol-Myers Squibb Company the past week has seen a gain of 5.48%. For the last month performance for Bristol-Myers Squibb Company is 1.76%. While the last quarter is 12.79% and half year, 11.31%. Finally for the year, performance is 11.85%.

The 52-week high for Bristol-Myers Squibb Company, is at -1.26%, and for the 52-week low it comes to a value of 45.69%. The 20-day simple moving average is 3.36% and 12.34% for the 200-day simple moving average.

Volatility for the week is at 1.49%, and for the month it is 1.66%. Bristol-Myers Squibb Company, has a target price of 76.48.

In terms of debt, long term debt/equity is 0.46, and for total debt/equity Bristol-Myers Squibb Company has 0.47. The gross margin is 76.00%, while operating margin is 11.60%, the profit margin is 9.30%. The current ratio is 1.5 and the quick ratio is 1.3.

Insider ownership is at 0.10%, with instituitional ownership at 74.40%. Bristol-Myers Squibb Company has a payout ratio of 159.00%. With the total shares outstanding coming to 1669. The shares float is 1666.37, with the float short at 1.05%, with short ratio coming to 2.96.

In terms of returns, the return on assets see Bristol-Myers Squibb Company, get 4.90%, with its returns on investment at 4.60%. Return on equity is 10.70%. So will the investors see the target price of 76.48, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment